Anti-Diabetic Effect of Aster sphathulifolius in C57BL/KsJ-db/db Mice

Journal of Medicinal Food

Volumn 18, Issue 9, 2015, Pages 987-998

  Yin, Xingfu ^a   Huang, Yuhua ^a   Jung, Da Woon ^a   Chung, Hee Chul ^b   Choung, Se Young ^c   Shim, Jae Hoon ^a   Kang, Il Jun ^a  

^a Hallym University   (South Korea)

^b Research and Development Institute   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Aster sphathulifolius; blood glucose; C57BL KsJ db db mice; diabetes mellitus; insulin resistance

Indexed keywords

ADIPOCYTE PROTEIN 2; ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; ASTER SPHATHULIFOLIUS EXTRACT; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTER SPHATHULIFOLIUS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; FLUID INTAKE; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID METABOLISM; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; ASTER (GENUS); BLOOD; C57BL MOUSE; CALORIC INTAKE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; DRUG EFFECTS; LIVER; METABOLISM; PHYTOTHERAPY;

ADIPOSE TISSUE; ANIMALS; ASTER PLANT; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; ENERGY INTAKE; GLUCOKINASE; GLUCOSE TOLERANCE TEST; GLUCOSE-6-PHOSPHATASE; HEMOGLOBIN A, GLYCOSYLATED; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; LIPID METABOLISM; LIVER; MALE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; PPAR GAMMA;

EID: 84941361196     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.3416     Document Type: Article

References (48)

1. DeFronzo RA: Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview. Diabetologia 1992;35: 389-397.
2. Yki-Jarvinen H: Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 1994;343:91-95.
3. Ferre T, Pujol A, Riu E, Bosch F, Valera A: Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci USA 1996;93:7225-7230.
4. Reaven GM: Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1993;9:5S-12S.
5. Bjornholm M, Zierath JR: Insulin signal transduction in human skeletal muscle: Identifying the defects in Type II diabetes. Biochem Soc Trans 2005;33:354-357.
6. Zisman A, Peroni OD, Abel ED, et al.: Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6:924-928.
7. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
8. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30:1000-1007.
9. Carvalho E, Kotani K, Peroni OD, Kahn BB: Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005;289:E551-E561.
10. Postic C, Shiota M, Niswender KD, et al.: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999;274:305-315.
11. Chatelain F, Pegorier JP, Minassian C, et al.: Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes 1998;47:882-889.
12. O'Brien RM, Granner DK: PEPCK gene as model of inhibitory effects of insulin on gene transcription. Diabetes Care 1990;13: 327-339.
13. Muoio DM, Newgard CB: Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:193-205.
14. Tontonoz P, Kim JB, Graves RA, Spiegelman BM: ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13:4753-4759.
15. Horton JD, Shimomura I: Sterol regulatory element-binding proteins: Activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999;10:143-150.
16. Fajas L, Schoonjans K, Gelman L, et al.: Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism. Mol Cell Biol 1999;19:5495-5503.
17. Kim JB, Wright HM, Wright M, Spiegelman BM: ADD1/ SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998;95:4333-4337.
18. Kim JB, Sarraf P, Wright M, et al.: Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998;101:1-9.
19. Flier JS, Hollenberg AN: ADD-1 provides major new insight into the mechanism of insulin action. Proc Natl Acad Sci USA 1999; 96:14191-14192.
20. Puigserver P, Spiegelman BM: Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator. Endocr Rev 2003;24:78-90.
21. Luna B, Feinglos MN: Oral agents in the management of type 2 diabetes mellitus. Am Fam Physician 2001;63:1747-1756.
22. Kim TJ: Wild Flowers of Korea. Kugilmedia, Seoul, Korea, 1996, p. 232.
23. Lee CB: Illustrated Flora of Korea. Hyangmoonsa, Seoul, Korea, 1999, p. 740.
24. Won JN, Lee SY, Song DS, Poo H: Antiviral activity of the plant extracts from Thuja orientalis, Aster sphathulifolius, and Pinus thunbergii against influenza virus A/PR/8/34. J Microbiol Biotechnol 2013;23:125-130.
25. Lee SO, Choi SZ, Choi SU, et al.: Labdane diterpenes from Aster sphathulifolius and their cytotoxic effects on human cancer cell lines. J Nat Prod 2005;68:1471-1474.
26. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-268.
27. Larsen ML, Horder M, Mogensen EF: Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 1990;323:1021-1025.
28. Stratton IM, Adler AI, Neil HA, et al.: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-412.
29. Hansen ME, Tippetts TS, Anderson MC, et al.: Insulin increases ceramide synthesis in skeletal muscle. J Diabetes Res 2014;2014: 765-784.
30. Coomans CP, Geerling JJ, Guigas B, et al.: Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulinsensitive mice. J Lipid Res 2011;52:1712-1722.
31. Hiriart M, Sanchez-Soto C, Diaz-Garcia CM, et al.: Hyperinsulinemia is associated with increased soluble insulin receptors release from hepatocytes. Front Endocrinol (Lausanne) 2014;5:95.
32. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E: Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997;46:1341-1345.
33. Liu J,Wu YY, Huang XM, et al.: Ageing and type 2 diabetes in an elderly chinese population: The role of insulin resistance and beta cell dysfunction. Eur Rev Med Pharmacol Sci 2014;18:1790-1797.
34. Campos G, Ryder E, Diez-Ewald M, et al.: Prevalence of obesity and hyperinsulinemia: Its association with serum lipid and lipoprotein concentrations in healthy individuals from Maracaibo, Venezuela. Invest Clin 2003;44:5-19.
35. Hansen J, Rinnov A, Krogh-Madsen R, et al.: Plasma follistatin is elevated in patients with type 2 diabetes: Relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation. Diabetes Metab Res Rev 2013;29:463-472.
36. Van Obberghen E, Baron V, Delahaye L, et al.: Surfing the insulin signaling web. Eur J Clin Invest 2001;31:966-977.
37. James DE, Strube M, Mueckler M: Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 1989;338:83-87.
38. Garvey WT, Birnbaum MJ: Cellular insulin action and insulin resistance. Baillieres Clin Endocrinol Metab 1993;7:785-873.
39. Pessin JE, Saltiel AR: Signaling pathways in insulin action: Molecular targets of insulin resistance. J Clin Invest 2000;106: 165-169.
40. McGarry JD: Disordered metabolism in diabetes: Have we underemphasized the fat component? J Cell Biochem1994;55:29-38.
41. Pirgon O, Bilgin H, Cekmez F, Kurku H, Dundar BN: Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2013;5:33-39.
42. Matschinsky FM: Regulation of pancreatic beta-cell glucokinase: From basics to therapeutics. Diabetes 2002;51:S394-S404.
43. Seoane J, Barbera A, Telemaque-Potts S, Newgard CB, Guinovart JJ: Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J Biol Chem 1999;274:31833-31838.
44. Misawa E, Tanaka M, Nomaguchi K, et al.: Oral ingestion of aloe vera phytosterols alters hepatic gene expression profiles and ameliorates obesity-associated metabolic disorders in zucker diabetic fatty rats. J Agric Food Chem 2012;60:2799-2806.
45. Acheson KJ, Schutz Y, Bessard T, Ravussin E, Jequier E, Flatt JP: Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. Am J Physiol 1984;246:E62-E70.
46. Ferre P, Foufelle F: Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010;12:83-92.
47. Ferre P: The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes 2004;53:S43-S50.
48. Baxa CA, Sha RS, Buelt MK, et al.: Human adipocyte lipidbinding protein: Purification of the protein and cloning of its complementary DNA. Biochemistry 1989;28:8683-8690.